Following the proposal of the Action Plan for the Health and Well-being Smart Specialisation Strategy (RIS3) and after several consultations between Xjenza Malta (formerly known as the Malta Council for Science and Technology (MCST)) and the Cancer Research and Innovation Hub Malta (CRIHM), a dedicated thematic programme for cancer research has been designed.   The Cancer Research Programme aims to support research that might in the future help reduce the incidence of cancer, improve cancer treatment, survival, and the quality of life of cancer patients.   The Cancer Research Programme aims to support capacity-building efforts related to:

• Molecular Research and Diagnostic Innovations
• Community-Based Cancer Research
• Therapeutic Development and Clinical Strategies
• Psychosocial Support and Patient-Centred Approaches

It aims to support fundamental and translational research including genetic, pharmacogenomic, proteomics, pharmaceutical, cellular, and pre-clinical in vivo research into the causes, mechanisms, diagnosis, treatment or prevention of cancer as well as research targeting psychosocial aspects of cancer, its treatment and survival.

Visit the below link to continue reading and download the application guidelines.

An online information session will be held on 28 June 2024, starting at 13:00. Click here to register.

Information and image source: